Page last updated: 2024-09-03

reboxetine and Panic Attacks

reboxetine has been researched along with Panic Attacks in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (75.00)29.6817
2010's1 (12.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Barbui, C; Bighelli, I; Caldwell, DM; Cipriani, A; Davies, SJ; Dawson, S; Dias, S; Furukawa, TA; Guaiana, G; Imai, H; Koesters, M; Meader, N; Pompoli, A; Robertson, L; Tajika, A1
Bellodi, L; Calati, R; Chiesa, A; De Ronchi, D; Perna, G; Serretti, A1
Dannon, PN; Grunhaus, L; Iancu, I1
Mohr, N; Muller, JE; Seedat, S; Stein, DJ; van Rheede van Oudtshoorn, E1
Bellodi, L; Bertani, A; Caldirola, D; Di Pasquale, D; Migliarese, G; Perna, G1
Bellodi, L; Bertani, A; Caldirola, D; Cucchi, M; Di Pasquale, D; Migliarese, G; Perna, G1
Schatzberg, AF1
Benedetti, A; Cassano, G; Mastalli, L; Nardi, A; Perugi, G; Savino, M; Versiani, M1

Reviews

3 review(s) available for reboxetine and Panic Attacks

ArticleYear
Pharmacological treatments in panic disorder in adults: a network meta-analysis.
    The Cochrane database of systematic reviews, 2023, 11-28, Volume: 11

    Topics: Adult; Alprazolam; Antidepressive Agents; Antidepressive Agents, Tricyclic; Benzodiazepines; Clomipramine; Clonazepam; Desipramine; Diazepam; Fluoxetine; Humans; Network Meta-Analysis; Panic Disorder; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Venlafaxine Hydrochloride

2023
Novel antidepressants and panic disorder: evidence beyond current guidelines.
    Neuropsychobiology, 2011, Volume: 63, Issue:1

    Topics: Antidepressive Agents; Clinical Trials as Topic; Cyclopropanes; Duloxetine Hydrochloride; Humans; Mianserin; Milnacipran; Mirtazapine; Morpholines; Panic Disorder; Practice Guidelines as Topic; Reboxetine; Thiophenes

2011
Clinical efficacy of reboxetine in major depression.
    The Journal of clinical psychiatry, 2000, Volume: 61 Suppl 10

    Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents, Tricyclic; Controlled Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Humans; Imipramine; Morpholines; Norepinephrine; Panic Disorder; Placebos; Reboxetine; Selective Serotonin Reuptake Inhibitors; Treatment Outcome

2000

Trials

5 trial(s) available for reboxetine and Panic Attacks

ArticleYear
The efficacy of reboxetine in the treatment-refractory patients with panic disorder: an open label study.
    Human psychopharmacology, 2002, Volume: 17, Issue:7

    Topics: Adrenergic Uptake Inhibitors; Adult; Agoraphobia; Antidepressive Agents; Drug Resistance; Female; Humans; Male; Morpholines; Panic Disorder; Psychiatric Status Rating Scales; Reboxetine; Selective Serotonin Reuptake Inhibitors

2002
Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study.
    International clinical psychopharmacology, 2003, Volume: 18, Issue:5

    Topics: Administration, Oral; Adrenergic Uptake Inhibitors; Adult; Citalopram; Comorbidity; Cross-Over Studies; Depression; Female; Humans; Male; Middle Aged; Morpholines; Panic Disorder; Pilot Projects; Reboxetine; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Treatment Outcome

2003
Modulation of hyperreactivity to 35% CO2 after one week of treatment with paroxetine and reboxetine: a double-blind, randomized study.
    Journal of clinical psychopharmacology, 2004, Volume: 24, Issue:3

    Topics: Adolescent; Adult; Analysis of Variance; Bronchial Hyperreactivity; Carbon Dioxide; Chi-Square Distribution; Double-Blind Method; Female; Humans; Male; Morpholines; Panic Disorder; Paroxetine; Reboxetine; Statistics, Nonparametric

2004
Comparison of the treatment with paroxetine and reboxetine in panic disorder: a randomized, single-blind study.
    Pharmacopsychiatry, 2004, Volume: 37, Issue:5

    Topics: Adrenergic Uptake Inhibitors; Adult; Female; Humans; Male; Morpholines; Panic Disorder; Paroxetine; Psychometrics; Reboxetine; Selective Serotonin Reuptake Inhibitors; Single-Blind Method

2004
Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder.
    The Journal of clinical psychiatry, 2002, Volume: 63, Issue:1

    Topics: Adrenergic Uptake Inhibitors; Adult; Agoraphobia; Comorbidity; Constipation; Double-Blind Method; Female; Humans; Male; Morpholines; Norepinephrine; Panic Disorder; Placebos; Psychiatric Status Rating Scales; Reboxetine; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Xerostomia

2002